The properties of tumor-initiating cells from a hepatocellular carcinoma patient's primary and recurrent tumor. - Wikidata - wikimedia - TriplyDB

The properties of tumor-initiating cells from a hepatocellular carcinoma patient's primary and recurrent tumor.

The properties of tumor-initiating cells from a hepatocellular carcinoma patient's primary and recurrent tumor.

http://www.wikidata.org/entity/Q43246238

about

Liver cancer stem cell markers: Progression and therapeutic implications The role of SOX2 in small cell lung cancer, lung adenocarcinoma and squamous cell carcinoma of the lung Functional Aspects of PARP1 in DNA Repair and Transcription.Autocrine Human Growth Hormone Promotes Invasive and Cancer Stem Cell-Like Behavior of Hepatocellular Carcinoma Cells by STAT3 Dependent Inhibition of CLAUDIN-1 Expression MicroRNA-1246 enhances migration and invasion through CADM1 in hepatocellular carcinoma.Genetic variations in the sonic hedgehog pathway affect clinical outcomes in non-muscle-invasive bladder cancer Expression of stemness genes in primary breast cancer tissues: the role of SOX2 as a prognostic marker for detection of early recurrence Therapeutic application of stem cells in gastroenterology: an up-date.Sry-box (Sox) transcription factors in gastrointestinal physiology and disease.Enhanced expression of stem cell markers and drug resistance in sphere-forming non-small cell lung cancer cells.Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway.Doxorubicin and 5-fluorouracil resistant hepatic cancer cells demonstrate stem-like properties Krüppel-like factor 8 promotes tumorigenic mammary stem cell induction by targeting miR-146a.Role of SOX2 in the etiology of embryonal carcinoma, based on analysis of the NCCIT and NT2 cell lines.Induced cancer stem cells generated by radiochemotherapy and their therapeutic implications.Tumor-initiating cells and tumor vascularization.Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating-cancer stem cells: distinct, overlapping or same populations.Twist2 promotes self-renewal of liver cancer stem-like cells by regulating CD24.8-Bromo-7-methoxychrysin-blocked STAT3/Twist axis inhibits the stemness of cancer stem cell-like cell originated from SMMC-7721 cells.PBX3 is targeted by multiple miRNAs and is essential for liver tumour-initiating cells.Genome-wide identification of differential methylation between primary and recurrent hepatocellular carcinomas.DNA methylation consistency implicates the primary tumor cell origin of recurrent hepatocellular carcinoma.PDCD5 transfection increases cisplatin sensitivity and decreases invasion in hepatic cancer cells.Overexpression of SOX2 promotes migration, invasion, and epithelial-mesenchymal transition through the Wnt/β-catenin pathway in laryngeal cancer Hep-2 cells.MicroRNA-9 enhances migration and invasion through KLF17 in hepatocellular carcinoma.Transforming growth factor-beta1 induces microvascular abnormalities through a down-modulation of neural cell adhesion molecule in human hepatocellular carcinoma.KIT polymorphisms were associated with the risk for head and neck squamous carcinoma in Chinese population.High expression FUT1 and B3GALT5 is an independent predictor of postoperative recurrence and survival in hepatocellular carcinoma.Recent advances of bispecific antibodies in solid tumors.MicroRNA-31 suppresses the self-renewal capability of α2δ1+ liver tumor-initiating cells by targeting ISL1.Sequential adaptive changes in a c-Myc-driven model of hepatocellular carcinoma.Evaluation of CD44 and CD133 as markers of liver cancer stem cells in Egyptian patients with HCV-induced chronic liver diseases versus hepatocellular carcinoma.RXRα enriched cancer stem cell-like properties triggered by CDDP in head and neck squamous cell carcinoma (HNSCC).Synergistic cytotoxicity of the poly (ADP-ribose) polymerase inhibitor ABT-888 and temozolomide in dual-drug targeted magnetic nanoparticles.Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44(high) metastatic subset in HCT116 colon cancer cells.Patient-derived multicellular tumor spheroids towards optimized treatment for patients with hepatocellular carcinoma.MicroRNA regulation of liver cancer stem cells

P2860

Q26751026-43263F77-CEC0-4404-A74E-DE0B505747BB Q26822879-A60CAF19-7F2E-4124-82D9-6D05A39CA899 Q33649584-E943BDF2-2B24-4A81-9AC2-EC033E749989 Q33838977-BDBC1D1F-32FB-4B07-9143-4AB53A36422E Q34116473-EDB373F2-05B3-497D-9D7F-E224072197B5 Q34203675-0124C0E6-5323-4F65-A646-0CEE5D3A5D40 Q34654576-D0DA6537-0978-4D93-AD76-220F1221B995 Q35404189-3154BF75-F769-4A02-BD54-05ED0AE155BB Q35825854-9DE9B4FC-2659-4E86-A84C-F51107F3AAB3 Q35918956-F50642CB-65EA-4CF8-A821-B3E2684290B6 Q36144913-32826521-C912-4AF5-BD37-EDAD055342AF Q36544739-F6BD94A4-C28D-4615-8322-15BB3BCE856D Q37039311-C8047C30-48CA-458B-965F-3873C72D0ECB Q37096462-44F9F22F-1708-4EF1-8BA3-D418CA31DB26 Q37431340-1AB20F06-228F-4A14-BFD9-72201266915B Q37725612-5DA61FE3-AD8E-4852-99BE-E8EC31696D70 Q37827825-0EFB5924-4E54-40EB-B99D-16A8FC86817D Q37885165-EB349C31-5206-4566-B908-D31EE846C37D Q38311444-18FEA2B3-8086-4A14-ADE2-7CF8560B204D Q38709245-AA600773-A174-45AF-8676-A7866B9953D9 Q38831430-029ABC29-B4DE-4EC1-BF0E-7CC91B3D4F7D Q38857159-3B2E1C15-8C94-46C7-9F0D-0977FE48D8C6 Q38894289-85EEFE55-A8A5-4FB2-A448-A05980B19859 Q38936648-8264B853-76A0-4D6A-85F3-0A134773114C Q38994534-CB69F2B2-F793-42E7-A728-30AD839A2021 Q39150597-C99F8B78-0BFE-440D-9B39-9B6664D77173 Q39325325-C6440699-55AB-4D48-BF82-41C0695BE517 Q40751221-04220354-DFD9-4E77-8818-FE381E77C0B6 Q41544461-BA04A2FD-96B0-4980-9AAE-7262A66912AA Q41696278-3AAF65DB-B266-41E0-B9AB-9195A29C8532 Q44848925-B32653A5-7478-48D8-9897-BEB2AAB10091 Q46378953-94483607-45CB-478B-BD21-548DFDE421A7 Q47142272-F3FE118D-3458-4CFE-801C-38B4B2B039E4 Q49935401-1B2700B2-5F4C-47EC-B619-F66DFE9E1E0A Q51735700-AA296D45-FC12-4496-A799-0EC057D4CC54 Q54359849-BB0B4AE5-15B9-4232-A195-DBB27D005ED2 Q55119883-4B4D555A-ED59-44F2-B5F8-64124999BBEC Q57177537-A13BEE84-2990-4BD4-9291-C32F2B8C4E84

P2860

The properties of tumor-initiating cells from a hepatocellular carcinoma patient's primary and recurrent tumor.

http://www.wikidata.org/entity/Q43246238

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

The properties of tumor-initia ...... s primary and recurrent tumor.

@en

The properties of tumor-initia ...... s primary and recurrent tumor.

@nl

type

label

The properties of tumor-initia ...... s primary and recurrent tumor.

@en

The properties of tumor-initia ...... s primary and recurrent tumor.

@nl

prefLabel

The properties of tumor-initia ...... s primary and recurrent tumor.

@en

The properties of tumor-initia ...... s primary and recurrent tumor.

@nl

P1433

Q43246238-BB296B4B-1CCD-49D9-9C0A-12316ED18580

P1476

Q43246238-D9E8BACC-0408-4C9E-B94F-8FA5FB8FDA1D

P2093

Q43246238-0E076B0A-E50E-427E-9974-1D7ABF537FC1

Q43246238-18E83909-3BEB-4BB2-B8C9-832E8AFC0C67

Q43246238-31EA6840-9364-4A8C-B5A5-3A90F2B742E9

Q43246238-3382AFA2-7F92-4B05-837D-03B022B859D4

Q43246238-45E6A114-BBE7-429A-BB8F-C8476BEB13CA

Q43246238-72FFC230-F6BB-49FE-B662-4B6A1ACAFC7F

Q43246238-880B78A6-0F7A-4705-B67D-AD00D77A238F

Q43246238-ABA82C63-EFA6-4394-BE8E-34D6FC1B8219

Q43246238-F6281D02-BB4C-4836-A0E3-F6BE48D74970

Q43246238-F7BE03F2-75A1-40F8-99F9-8C8C4C1A8BC4

P2860

Q43246238-011FCC7F-FFED-40A1-87D4-D5A1F2AB206B

Q43246238-0656962A-0B52-46CE-B8FF-BD0CCBBCF60A

Q43246238-07EF0C53-801D-4DF3-B7C3-B31B925A6C1A

Q43246238-0E5C7226-D878-45F1-8E0E-1D29730F329D

Q43246238-157D56A1-DFA3-48EB-824C-6C33F9334670

Q43246238-21CE37FD-0581-419E-928B-30811BBF8337

Q43246238-244426A4-A9C4-4214-A854-F8C8BFADB7A1

Q43246238-3091AF65-2FB6-4DB8-B70E-70DC8FE5C43D

Q43246238-30C3D407-08EB-4FE6-A6E3-F4C5ED81D792

Q43246238-3C2924DC-C814-44F2-9CD7-652C5004B452

P304

Q43246238-83EC98B5-6050-4E46-8D1E-CFF8DF596DAD

P31

Q43246238-CA73B385-92AC-4A59-90CF-3C0294160719

P356

Q43246238-AB76A65D-8EEE-4F13-A3FB-9DD3E1B8AB58

P407

Q43246238-AE527E55-FC5D-4DC7-962D-AD24297F4C37

P433

Q43246238-7B3CB17F-60C7-4540-9B02-8AC1F8D83240

P478

Q43246238-6EF1CA38-BB19-45C5-91C4-A36BE20B58F0

P50

Q43246238-2DF122B2-B9B9-4E85-94A1-FCD1953099DA

P577

Q43246238-ECF93AB8-7BCB-44AF-8632-95202921BE49

P5875

Q43246238-6BB23A7F-1BFF-4A1A-8376-AB27B2CD63BA

P698

Q43246238-D9989DF2-C37C-4D17-8748-07C88E3E1777

P356

P1433

P1476

The properties of tumor-initia ...... 's primary and recurrent tumor

@en

P2093

Bao-Cai Xing

http://www.w3.org/2001/XMLSchema#string

Hai-Bo Han

http://www.w3.org/2001/XMLSchema#string

Ji-You Li

http://www.w3.org/2001/XMLSchema#string

Jun Gu

http://www.w3.org/2001/XMLSchema#string

Mei-Hao Hu

http://www.w3.org/2001/XMLSchema#string

Wei Zhao

http://www.w3.org/2001/XMLSchema#string

Xiao-Lan Xu

http://www.w3.org/2001/XMLSchema#string

Yong Xie

http://www.w3.org/2001/XMLSchema#string

Yu Wang

http://www.w3.org/2001/XMLSchema#string

Zuo-Liang Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Core transcriptional regulatory circuitry in human embryonic stem cells

Efficient tumour formation by single human melanoma cells

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

Stem cells, cancer, and cancer stem cells

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

let-7 regulates self renewal and tumorigenicity of breast cancer cells

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells

Significance of CD90+ cancer stem cells in human liver cancer

Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro

P304

167-174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CARCIN/BGP232

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38074826

http://www.w3.org/2001/XMLSchema#string

P698

19897602

http://www.w3.org/2001/XMLSchema#string